As for therapeutic applications, our study indicated that FLT3-ITD promotes immune checkpoint CD80 via ROS elevation in AML and the HIF-1α inhibition, further ROS overproduction functions as a pro-death signal and induces CD80 overexpression. The gene discussed is CD80; the disease is acute myeloid leukemia.